WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009136850) MUSCARINIC RECEPTOR AGONISTS USEFUL IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/136850    International Application No.:    PCT/SE2009/050477
Publication Date: 12.11.2009 International Filing Date: 04.05.2009
IPC:
C07D 401/04 (2006.01), A61K 31/517 (2006.01), A61K 31/538 (2006.01), A61P 25/04 (2006.01), A61P 25/18 (2006.01), A61P 25/28 (2006.01), C07D 413/04 (2006.01)
Applicants: ASTRAZENECA AB [SE/SE]; S-151 85 Södertälje (SE) (For All Designated States Except US).
CHENG, Yun-Xing [CA/CA]; (CA) (For US Only).
SANTHAKUMAR, Vijayaratnam [LK/CA]; (CA) (For US Only).
TOMASZEWSKI, Miroslaw Jerzy [CA/CA]; (CA) (For US Only)
Inventors: CHENG, Yun-Xing; (CA).
SANTHAKUMAR, Vijayaratnam; (CA).
TOMASZEWSKI, Miroslaw Jerzy; (CA)
Agent: CIARDI, Joseph, A.; Connoly Bove Lodge @Hutz LLP The Nemours Building 1007 Orange Street Wilmington, DE 19899 (US)
Priority Data:
61/050,343 05.05.2008 US
Title (EN) MUSCARINIC RECEPTOR AGONISTS USEFUL IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA
(FR) AGONISTES DES RÉCEPTEURS MUSCARINIQUES UTILES DANS LE TRAITEMENT DE LA DOULEUR, DE LA MALADIE D’ALZHEIMER ET DE LA SCHIZOPHRÉNIE
Abstract: front page image
(EN)Compounds of Formula (I), or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, R4, m, n, q, s, t, X, and Y are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
(FR)La présente invention concerne la préparation de composés de formule (I), ou de leurs sels pharmaceutiquement acceptables : où R1, R2, R3, R4, m, n, q, s, t, X, et Y sont tels que définis dans la description, ainsi que de sels et de compositions pharmaceutiques comprenant les composés. Ils sont utiles en thérapie, en particulier dans la prise en charge de la douleur.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)